Does Myomectomy for Intramural Fibroid Improve ART Outcome?
Launched by MANSOURA UNIVERSITY · Jan 4, 2019
Trial Information
Current as of September 14, 2025
Unknown status
Keywords
ClinConnect Summary
This study will include women who have intramural myoma ranging from 3-5 cm
The participants will be randomly allocated into two groups.
In group (1): myomectomy will be performed before ART
In group (2):women will have their trial of ART without myomectomy
In group A, ART will be performed 3 months after myomectomy if the uterine cavity is not opened and 6 months after myomectomy upon inadvertent opening of the uterine cavity during surgery
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- * Inclusion criteria:
- • Women with intramural fibroid without any cavity involvement
- • Age ˂ 35 years
- • I onCSI or IVF cycles
- • normal uterine cavity
- Exclusion Criteria:
- * Exclusion criteria:
- • low ovarian reserve (AFC \< 7 and or AMH \< 1.1 ng/ml)
- • Endometrioma
- • Untreated hydrosalpinx
- • Non obstructive azoospermia
- • Any other cavitary lesions (Asherman syndrome, Mullerian anomalies)
- • recurrent implantation failure
About Mansoura University
Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansoura, Dakahlia, Egypt
Patients applied
Trial Officials
Ahmed Gibreel, MD
Principal Investigator
Mansoura University
Mohamed S Abdelhafez, MD
Study Director
Mansoura University
Salah Rasheed, MD
Study Director
Sohag University
Ahmed Nasr, MD
Study Director
Assiut Universit
Hisham A Saleh, MD
Study Director
Alexandria University
Hassan El Maghraby, MD
Study Director
Alexandria University
Eman El Gindy, MD
Study Chair
Zagazig University
Hoda Sibai, MD
Study Director
Zagazig University
Hamed Yossef, MD
Study Chair
Mansoura University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials